163 related articles for article (PubMed ID: 31838972)
21. Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.
Lee CY; Huntley BK; McCormick DJ; Ichiki T; Sangaralingham SJ; Lisy O; Burnett JC
Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):98-105. PubMed ID: 27340557
[TBL] [Abstract][Full Text] [Related]
22. alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock.
Hartemink KJ; Groeneveld AB; de Groot MC; Strack van Schijndel RJ; van Kamp G; Thijs LG
Crit Care Med; 2001 Jan; 29(1):80-7. PubMed ID: 11176165
[TBL] [Abstract][Full Text] [Related]
23. Endogenous Sex Hormones and Endothelial Function in Postmenopausal Women and Men: The Multi-Ethnic Study of Atherosclerosis.
Mathews L; Subramanya V; Zhao D; Ouyang P; Vaidya D; Guallar E; Yeboah J; Herrington D; Hays AG; Budoff MJ; Michos ED
J Womens Health (Larchmt); 2019 Jul; 28(7):900-909. PubMed ID: 31170017
[No Abstract] [Full Text] [Related]
24. Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study.
Brutsaert EF; Biggs ML; Delaney JA; Djoussé L; Gottdiener JS; Ix JH; Kim F; Mukamal KJ; Siscovick DS; Tracy RP; de Boer IH; deFilippi CR; Kizer JR
Metabolism; 2016 Oct; 65(10):1489-97. PubMed ID: 27621184
[TBL] [Abstract][Full Text] [Related]
25. Plasma cyclic GMP concentrations and their relationship with changes of blood pressure levels in pre-eclampsia.
Schneider F; Lutun P; Baldauf JJ; Quirin L; Dreyfus M; Ritter J; Tempé JD
Acta Obstet Gynecol Scand; 1996 Jan; 75(1):40-4. PubMed ID: 8560995
[TBL] [Abstract][Full Text] [Related]
26. Genetics of NO Deficiency.
Leineweber K; Moosmang S; Paulson D
Am J Cardiol; 2017 Oct; 120(8S):S80-S88. PubMed ID: 29025574
[TBL] [Abstract][Full Text] [Related]
27. Comparison of cyclic guanosine monophosphate response to infusion of atrial natriuretic peptide in young and elderly subjects.
Tan AC; Jansen TL; Thien T; Kloppenborg PW; Benraad TJ
J Am Geriatr Soc; 1993 Nov; 41(11):1241-4. PubMed ID: 8227900
[TBL] [Abstract][Full Text] [Related]
28. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.
Lettgen B; Bald M; Valleé H; Bonzel KE; Rascher W
Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187
[TBL] [Abstract][Full Text] [Related]
29. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.
Potter LR; Abbey-Hosch S; Dickey DM
Endocr Rev; 2006 Feb; 27(1):47-72. PubMed ID: 16291870
[TBL] [Abstract][Full Text] [Related]
30. Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
Takahama H; Takashio S; Nishikimi T; Hayashi T; Nagai-Okatani C; Nakagawa Y; Amaki M; Ohara T; Hasegawa T; Sugano Y; Kanzaki H; Yasuda S; Kangawa K; Minamino N; Anzai T
Int J Cardiol; 2018 May; 258():165-171. PubMed ID: 29544926
[TBL] [Abstract][Full Text] [Related]
31. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
[TBL] [Abstract][Full Text] [Related]
32. A population-based study of plasma cyclic guanosine monophosphate: relations to age, atrial natriuretic factor and angiotensin-converting enzyme activity.
Nyström FH; Ahlner J; Karlberg BE; Ohman PK
Scand J Clin Lab Invest; 1998 Dec; 58(8):605-10. PubMed ID: 10088196
[TBL] [Abstract][Full Text] [Related]
33. Relationship of urinary cGMP excretion with aging and menopausal status in a general population.
Cui R; Iso H; Yamagishi K; Ohira T; Tanigawa T; Kitamura A; Kiyama M; Imano H; Konishi M; Shimamoto T
J Atheroscler Thromb; 2009 Aug; 16(4):457-62. PubMed ID: 19672035
[TBL] [Abstract][Full Text] [Related]
34. [Values of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in cardioversion].
Lechleitner P; Genser N; Hauptlorenz S; Putensen C; Mitterschiffthaler G; Artner-Dworzak E; Puschendorf B; Dienstl F
Z Kardiol; 1991 Sep; 80(9):574-9. PubMed ID: 1661054
[TBL] [Abstract][Full Text] [Related]
35. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
Hypertension; 2005 Oct; 46(4):660-6. PubMed ID: 16129819
[TBL] [Abstract][Full Text] [Related]
36. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
[TBL] [Abstract][Full Text] [Related]
37. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
[TBL] [Abstract][Full Text] [Related]
38. The association between N-terminal pro B-type natriuretic peptide and lipoprotein particle concentration plateaus at higher N-terminal pro B-type natriuretic peptide values: Multi-Ethnic Study on Atherosclerosis.
Sanchez OA; Duprez DA; Daniels LB; Maisel AS; Otvos JD; Peralta CA; Lima JA; Bahrami H; Jacobs DR
Metabolism; 2015 Aug; 64(8):857-61. PubMed ID: 25931335
[TBL] [Abstract][Full Text] [Related]
39. Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure.
Supaporn T; Sandberg SM; Borgeson DD; Heublein DM; Luchner A; Wei CM; Dousa TP; Burnett JC
Kidney Int; 1996 Nov; 50(5):1718-25. PubMed ID: 8914042
[TBL] [Abstract][Full Text] [Related]
40. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.
Ouyang P; Vaidya D; Dobs A; Golden SH; Szklo M; Heckbert SR; Kopp P; Gapstur SM
Atherosclerosis; 2009 May; 204(1):255-61. PubMed ID: 18849030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
